SP
ALXN

Symmetry Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Symmetry Partners’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,683
Closed -$493K – 685
2021
Q2 		$493K Hold
2,683
– – 0.03% 433
2021
Q1 		$410K Sell
2,683
-39
-1% -$5.96K 0.03% 472
2020
Q4 		$425K Buy
2,722
+21
+0.8% +$3.28K 0.03% 423
2020
Q3 		$309K Buy
+2,701
New +$309K 0.03% 480